Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Social and Behavioral Sciences, University of California San Francisco School of Nursing, San Francisco, CA, USA.
Ethn Health. 2020 Apr;25(3):393-407. doi: 10.1080/13557858.2018.1427703. Epub 2018 Jan 18.
To ascertain the magnitude and potential mechanisms of racial/ethnic disparities in initiating and completing the 3-dose human papillomavirus (HPV) vaccine among U.S. women in the post-Affordable Care Act era. Using 2015 National Health Interview Survey data, we used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for the association between race/ethnicity and HPV vaccination initiation and completion among black, Latina, Asian, and white U.S. women aged 18-31 years, adjusting for age and geographic region. We also examined the role of socioeconomic and health care factors in potentially explaining racial/ethnic disparities in HPV vaccine uptake and stratified our analyses by age (ages 18-22 and 23-31 years). The prevalence of HPV vaccination initiation and completion among U.S. women aged 18-31 years overall was 35.4% and 22.7%, respectively. We observed no statistically significant difference in the odds of HPV vaccination initiation or completion by race/ethnicity among women aged 18-22 years, adjusting for age and geographic region. Among women aged 23-31 years, Latina ([odds ratio=] 0.59; [95% confidence interval:] 0.47, 0.76) and Asian (0.51; 0.34, 0.75) women had significantly lower adjusted odds of initiating HPV vaccination compared to white women. Further, relative to white women, black (0.46; 0.32, 0.67), Latina (0.45; 0.32, 0.64), and Asian (0.46; 0.28, 0.78) women had significantly lower adjusted odds of completing HPV vaccination. Adding socioeconomic factors to the models attenuated the HPV vaccination initiation adjusted odds ratios for Latina vs. white women and the HPV vaccination completion adjusted odds ratios for both black and Latina vs. white women. The inclusion of health care factors into the models did not further attenuate these odds ratios. Policies and programs that promote socioeconomic equity may mitigate HPV vaccination disparities between black and Latina women and white women. Additional research is needed to identify the drivers of HPV vaccination disparities between subgroups of Asian women and white women.
为了确定在平价医疗法案实施后,美国女性中启动和完成 3 剂人乳头瘤病毒(HPV)疫苗接种的种族/民族差异的程度和潜在机制。利用 2015 年全国健康访谈调查数据,我们使用逻辑回归来估计种族/民族与 HPV 疫苗接种启动和完成之间的关联的优势比(OR)和 95%置信区间(CI),在调整年龄和地理位置后,比较了美国 18-31 岁的黑人、拉丁裔、亚裔和白人女性。我们还检查了社会经济和医疗保健因素在解释 HPV 疫苗接种率种族/民族差异方面的作用,并按年龄(18-22 岁和 23-31 岁)对我们的分析进行了分层。美国 18-31 岁女性 HPV 疫苗接种启动和完成的总体流行率分别为 35.4%和 22.7%。在调整年龄和地理位置后,我们没有观察到年龄在 18-22 岁的女性中 HPV 疫苗接种启动或完成的几率在种族/民族之间存在统计学上的显著差异。在年龄在 23-31 岁的女性中,拉丁裔(比值比=0.59;95%置信区间:0.47,0.76)和亚裔(0.51;0.34,0.75)女性与白人女性相比,HPV 疫苗接种启动的调整后优势比明显较低。此外,与白人女性相比,黑人(0.46;0.32,0.67)、拉丁裔(0.45;0.32,0.64)和亚裔(0.46;0.28,0.78)女性完成 HPV 疫苗接种的调整后优势比也明显较低。在模型中加入社会经济因素后,降低了拉丁裔与白人女性相比的 HPV 疫苗接种启动调整优势比,以及黑人和拉丁裔与白人女性相比的 HPV 疫苗接种完成调整优势比。将医疗保健因素纳入模型并没有进一步降低这些优势比。促进社会经济公平的政策和计划可能会减轻黑人和拉丁裔女性与白人女性之间的 HPV 疫苗接种差异。需要进一步研究以确定亚裔女性和白人女性之间 HPV 疫苗接种差异的驱动因素。